DURECT Corporation ( DRRX) - Key Metrics
Stock symbol DRRX is outdated, potentially delisted? Maybe it is available on other exchange?
DRRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.01 | -$0.07 | ? | ? |
| 2025Q1 | $0.01 | -$0.14 | -$0.11 | -$0.11 |
| 2024Q4 | $0.01 | $0.24 | -$0.18 | -$0.18 |
| 2024Q3 | $0.06 | -$0.14 | -$0.10 | -$0.10 |
| 2024Q2 | $0.07 | -$0.12 | -$0.12 | -$0.12 |
DRRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -2.18 |
| 2025Q1 | ? | -1.47 |
| 2024Q4 | ? | 0.80 |
| 2024Q3 | ? | -2.43 |
| 2024Q2 | ? | -2.75 |
DRRX
Price: $1.91
52 week price:
Earnings Per Share: -0.43 USD
P/E Ratio: -4.44
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 37400
Ebitda: 6.8 millionMarket Capitalization: 59.3 million